MedPath

MEXBRAIN

🇫🇷France
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

2

Active:1
Completed:0

Trial Phases

1 Phases

Not Applicable:2

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials

Not Applicable
2 (100.0%)

Feasibility Pilot Study to Evaluate the Safety and Performance of the MEX-CD1 Medical Device in ACLF

Not Applicable
Recruiting
Conditions
Acute on Chronic Liver Failure
Multiple Organ Failure
First Posted Date
2024-04-01
Last Posted Date
2025-05-08
Lead Sponsor
Mexbrain
Target Recruit Count
10
Registration Number
NCT06340269
Locations
🇫🇷

Hôpital Croix Rousse, Service d'hépatologie et gastroentérologie, Lyon, Rhône-Alpes, France

🇫🇷

CHU Pontchaillou, Rennes, France

Performance and Safety of MEX-CD1 Low-volume Continuous Veno-venous Haemodialysis Medical Device for Copper-extraction in Patients With Wilson's Disease

Not Applicable
Active, not recruiting
Conditions
Hepatolenticular Degeneration; Wilson
First Posted Date
2023-06-23
Last Posted Date
2025-05-08
Lead Sponsor
Mexbrain
Target Recruit Count
17
Registration Number
NCT05917327
Locations
🇫🇷

Hôpital Femme Mère Enfant, Service des urgences et la réanimation pédiatriques, Bron, Rhône-Alpes, France

🇫🇷

Hôpital Croix Rousse, Service d'hépatologie et gastroentérologie, Lyon, Rhône-Alpes, France

🇪🇸

Hospital Universitario Vall d'Hebron, Unitat de Trasplantament Hepàtic Pediàtric, Barcelona, Catalonia, Spain

and more 1 locations

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.